Lapatinib - Globe Thesis

Keyword [Lapatinib] Result: 1 - 20 \| Page: 1 of 3
1.	Lapatinib In Combination With Bortezomib Inhibits Breast Cancer Cells Growth And The Activity Of Bortezomib To Lapatinib-resistant Breast Cancer Cell
2.	The Mechanism Of Apoptosis Induced By Lapatinib In Her2 Positive Breast Cancer Cells And Synergistic Effective Between ABT-737 And Lapatinib
3.	Synthesis Of Thietane Derivatives And Study On Synthesis Of Transition Metal Catalysts
4.	To Evaluate Efficacy And Safety Of Lapatinib In Combination With Paclitaxel In Subjects With HER-2 Amplified Metastatic Breast Cancer
5.	Study On The Synthesis Of Lapatinib And Its Intermediates
6.	The Effect Of Lapatinib And DPP On Cervical Adenocarcinoma Cells And Its Mechanism
7.	The Growth Inhibition Of PTEN Low Expressed Breast Cancer Cells Induced By Combinational Therapy With Lapatinib And Scr Inhibitor-AZD0530
8.	ErbB2T798I Mediated Drug Resistance To Lapatinib In Breast Cancers And The Tumor Suppressor Role Of PHLDA1/2in Breast And Lung Cancers
9.	The Design And Evaluation Of Brain Tumor Targeted Drug Delivery Systems Based On Different Strategies
10.	Insulin Receptor/Insulin-like Growth Factor1Receptor Pathway Confers Resistance Of Lapatinib In HER-2Positive Gastric Cancer Cell Lines
11.	Expression Of EGFR/HER-2in Esophageal Squamous Cell Carcinoma And The Anti-tumor Effects And Mechanisms Of Lapatinib In Combination With Chemotherapeutic Agents
12.	The Effection Of Lapatinib Combination With Cisnlatin On Human Ovarian Cancer Cell SKOV3and Study On Its Mechanism
13.	The Effections Of Novel Targeting Agent Lapatinib In Human Ovarian Cancer Cell Line SKOV3
14.	Design, Synthesis And Biological Evaluation Of Salicylanilides Derivatives
15.	Mechanism Of Lapatinib-induced Cell Tolerance From The Perspective Of Metabolic Changes In ErbB2Positive Breast Cancer Cells
16.	Study On The Relationship Between Autophagy And Anti-tumor Activitiy Of Lapatinib In HER2Positive Breast Cancer Cells
17.	Targeting Specific P110α Isoform In ErbB2Overexpressing/PTEN-deficient Breast Cancer
18.	The Mechanism Of FW-04-806Against HER2-overexpressing Breast Cancer Cells And Its Synergistic Effect With Lapatinib
19.	The Mechanism Of HER3Activation In Gastric Cancer Resistance To Lapatinib
20.	Lapatinib Reverses ER-α36-associated Tamoxifen Resistance In Breast Cancer Cells
<<First <Prev Next> Last>> Jump to